by

Tim Ferriss

Rick Doblin — The Psychedelic Domino That Tips All Others (#440)

23 comments

Topics:
Rick Doblin speaking onstage.
Photo courtesy of MAPS

Rick Doblin, PhD, (@rickdoblin) is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in public policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. Rick was also one of the early students under the legendary Dr. Stanislav Grof.

Please listen to this entire episode, as there is a $10M surprise at the end.

If you are interested in learning more about MAPS’s critical work and Phase 3 studies to make MDMA-assisted psychotherapy an approved treatment for PTSD, please visit maps.org/capstone.

Listen to the episode on Apple Podcasts, Spotify, Overcast, Stitcher, Castbox, Google Podcasts, or on your favorite podcast platform. You can find the transcript of this episode here. Transcripts of all episodes can be found here.

#440: Rick Doblin — The Psychedelic Domino That Tips All Others

This episode is brought to you by Helix Sleep! Helix was named best overall mattress of 2026 by Forbes, Wired, and Sleepopolis; best mattress for couples by Oprah Daily; and one of the most trusted brands of 2026 by USA Today. With Helix, there’s a specific mattress to meet each and every body’s unique comfort needs. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk-free. They’ll even pick it up from you if you don’t love it. And now, Helix is offering listeners 20% off sitewide for a limited time at HelixSleep.com/Tim.

What was your favorite quote or lesson from this episode? Please let me know in the comments.

SCROLL BELOW FOR LINKS AND SHOW NOTES…

Want to learn more about psychedelic therapy from another pioneer in this field? Listen to my conversation with the legendary Stan Grof, in which we discuss the takeaways from guiding 4,500+ LSD sessions, the place and role of wounded healers, limitations and uses of traditional psychoanalysis and talk therapy, the similarities found between holotropic breathwork and MDMA, what humanity most needs to overcome, and much more.

#347: Stan Grof, Lessons from ~4,500 LSD Sessions and Beyond

SELECTED LINKS FROM THE EPISODE

  • Connect with Rick Doblin:

Twitter | Facebook | Instagram

  • Connect with MAPS:

Website | Twitter | Facebook | Instagram

SHOW NOTES

  • What is MAPS, and how did MAPS come to be? [05:42]
  • What is MDMA — where did it come from, and how did it find its way into the therapeutic context? [08:51]
  • What was Sasha Shulgin’s role in the history of psychedelics, and how did he operate a lab to study them openly without suffering legal consequences? [18:08]
  • Who is Jon Lubecky, and why did he come into Rick’s life? [21:43]
  • Why does Rick believe psychedelic therapy not only allows sufferers of PTSD to tolerably revisit and come to terms with their traumatic experiences, but also enjoy the benefits for months or even years after the chemical components of this therapy have faded? [29:58]
  • What are the biggest differences between MDMA and the less well-known MDA? [39:31]
  • Rick talks about his first psychedelic therapy sessions with a PTSD patient back in 1984, their short- and long-term effects, and how that patient went on to become an important asset to the MAPS community. [42:42]
  • For Rick and his colleagues, what has made the rewards of psychedelic therapy worth enduring its risks — especially in the not-so-distant past when it was legally dangerous and considered career suicide for its practitioners? [57:06]
  • The suicide note that reached Rick when help came too late, and what it emphasized about the importance of his life’s work. [1:00:00]
  • What the present and future look like for MDMA reclassification and its therapeutic use, and why matching grants make now the ideal time for prospective contributors to get the most mileage from their money. [1:04:04]
  • Up until recently, anyone associated with psychedelic therapies could expect to suffer a blow to their reputation, but the times are changing, and my own experience has proven quite the opposite. [1:07:19]
  • How much would you pay for 100 percent reputational upside in making MDMA-assisted therapies available to the thousands in need? [1:30:10]
  • Parting thoughts. [1:32:29]

PEOPLE MENTIONED

Subscribe
Notify of
guest

Comment Rules: Remember what Fonzie was like? Cool. That's how we're gonna be — cool. Critical is fine, but if you're rude, we'll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for adding to the conversation! (Thanks to Brian Oberkirch for the inspiration.)

23 Comments
Oldest
Newest Most Voted

Keep exploring.